INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 422m ago
House PTR22m ago
SEC 13F21m ago
Robinhood Chain21m ago

Results

20,939 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
SC
Sumner CrystalSee Remarks
MQMarqeta, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
5,056 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

Page 240 of 524
← PrevNext →
16
AA
Aragone AugustoExecutive VP, Secretary & GC
INGMIngram Micro Holding Corp
Open-market sale · 10b5-1 plan
SELL
$300K
10.0K sh
Jun 15, 2026
Jun 16, 2026
traded Jun 15, 2026
+1d
SEC Form 4

Evidence

15
MP
McQuarrie David P.Chief Commercial Officer
HPQHP INC
Open-market sale · 10b5-1 plan
SELL$260K
10.5K sh
Jun 12, 2026Jun 16, 2026
traded Jun 12, 2026
+4dSEC Form 4

Evidence

15
AF
Ahearn Matthew FraserDirector, Chief Operating Officer
SISHOULDER INNOVATIONS, INC.
Open-market sale · 10b5-1 plan
SELL$296K
15.9K sh
Jun 12, 2026Jun 16, 2026
traded Jun 12, 2026
+4dSEC Form 4

Evidence

14
RY
Rozenberg Haine YaelVP Finance
VLNValens Semiconductor Ltd.
Open-market sale · 10b5-1 plan
SELL$41K
17.4K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

13
VH
von Heynitz HaraldDirector
FLNCFluence Energy, Inc.
Open-market sale · 10b5-1 plan
SELL$125K
5,000 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

12
EM
Ellenbogen MichaelDirector
EVLVEvolv Technologies Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$501K
80.7K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

11
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
116 sh
Jun 16, 2026Jun 16, 2026
traded Jun 16, 2026
+0dSEC Form 4

Evidence

10
RY
Rozenberg Haine YaelVP Finance
VLNValens Semiconductor Ltd.
Open-market sale · 10b5-1 plan
SELL$3,429
1,453 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

4
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
1,596 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

4
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Open-market sale · 10b5-1 plan
SELL$881K
57.9K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

4
PJ
Prahm JeremyChief Investment Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$181K
8,860 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

4
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$135K
2,104 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

3
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Open-market sale · 10b5-1 plan
SELL$9,730
4,000 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
200 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
AF
Ahearn Matthew FraserDirector, Chief Operating Officer
SISHOULDER INNOVATIONS, INC.
Open-market sale · 10b5-1 plan
SELL$48K
2,500 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
AF
Ahearn Matthew FraserDirector, Chief Operating Officer
SISHOULDER INNOVATIONS, INC.
Open-market sale · 10b5-1 plan
SELL$30K
1,644 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$6,563
100 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

1
FJ
Fiedler-Kelly JillPresident, Services Solutions
SLPSimulations Plus, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
1,050 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

0
AE
Alvarez Divo Carlos EduardoDirector
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
10.7K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC Form 4

Evidence

51
RA
Rosenberg AaronChief Financial Officer
ONCBeOne Medicines Ltd.
Open-market sale
SELL$163K
631 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

50
HJ
Haas JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$886K
3,461 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

50
HJ
Haas JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$765K
3,000 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

47
WL
Wang LaiPresident, Global Head of R&D
ONCBeOne Medicines Ltd.
Open-market sale
SELL$197K
756 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

44
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale
SELL$110K
428 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

43
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$2.67M
23.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

40
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$878K
7,500 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

40
AL
Anderson Dyaarl Lee Jr.Chief Commercial Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$9,525
4,739 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

39
AG
Abbott Paul GDirector, Chief Executive Officer
GBTGGlobal Business Travel Group, Inc.
Open-market sale
SELL$5.37M
574.3K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

37
BS
Bulis Veronica SanchezVP, Corporate Controller
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$4,103
217 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC Form 4

Evidence

37
HJ
Hill Stephen J.Chief Operating Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$1,684
89 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC Form 4

Evidence

37
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$445K
3,418 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

37
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$2,460
130 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC Form 4

Evidence

36
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$524K
4,449 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

36
ID
Inglis Tiffany Eul DavisChief Medical Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$728
362 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

32
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$279K
2,348 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

32
AA
Aerts AustinChief Financial Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$4,094
2,037 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

32
LZ
Lindgardt ZhenyaDirector, Chief Executive Officer
SERASERA PROGNOSTICS, INC.
Open-market sale
SELL$14K
6,990 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

31
FL
Feldmann Cynthia LDirector
UFPTUFP TECHNOLOGIES INC
Open-market sale
SELL$263K
1,100 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

31
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$961K
10.4K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence